Ségolène Bisot-Locard

Octreotide (Long-Acting Release Formulation) Treatment in Patients with Graves’ Orbitopathy: Clinical Results of a Four-Month, Randomized, Placebo-Controlled, Double-Blind Study

J.-L. Wémeau, Philippe Caron, Albert Beckers et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 82 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

The estimated incidence of gastrointestinal stromal tumors in France. Results of PROGIST study conducted among pathologists

Geneviève Monges, Ségolène Bisot-Locard, Jean‐Yves Blay et al. · Bulletin du Cancer · 2010 · 63 citations

Medicine, Oncology, Pathology +11

Professional Practices and Diagnostic Issues in Neuroendocrine Tumour Pathology: Results of a Prospective One-Year Survey among French Pathologists (the PRONET Study)

Jean‐Yves Scoazec, Anne Couvelard, Geneviève Monges et al. · Neuroendocrinology · 2016 · 47 citations

Medicine, Oncology, Pathology +12

Predictive Factors of Somatostatin Receptor Ligand Response in Acromegaly—A Prospective Study

Mirela Diana Ilie, Antoine Tabarin, Alexandre Vasiljevic et al. · The Journal of Clinical Endocrinology & Metabolism · 2022 · 47 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

SALTO: a randomized, multicenter study assessing octreotide LAR in inoperable bowel obstruction

Guillemette Laval, Hubert Rousselot, Sophie Toussaint-Martel et al. · Bulletin du Cancer · 2012 · 44 citations

Medicine, Clinical Sciences, Surgery +15